What is the current price and market cap of 4592.T stock?

As of pre-market 18 Mar 2026, 4592.T stock trades at JPY 1,985.00 with a market cap of JPY 157,616,141,860.00. Volume is 746,900.00 shares, below the 50-day average of 1,374,133.00.

How does SanBio’s earnings affect 4592.T stock outlook?

Earnings drive sentiment for 4592.T stock because SanBio is loss-making (EPS -50.47). Positive clinical or licensing news tied to earnings can lift valuation; weak guidance or cash concerns can increase downside and dilution risk.

What are Meyka AI’s forecast and price target for 4592.T stock?

Meyka AI's forecast model projects a monthly target of JPY 2,286.54 and a quarterly target of JPY 3,930.32 for 4592.T stock. These imply potential upside of about 15.20% and 98.06% versus the current price of JPY 1,985.00.

What are the main risks for investors in 4592.T stock?

Key risks for 4592.T stock include negative profitability, high price-to-book, trial failures, regulatory delays, and potential share dilution if SanBio needs financing. Leverage (debt/equity 2.64) also raises refinancing risk.

JP Stocks

SanBio (4592.T JPX) pre-market 18 Mar 2026: earnings will shape JPY 1,985 outlook

ByDanny Kontos March 17, 2026March 17, 2026

SanBio Company Limited (4592.T) trades at JPY 1,985.00 pre-market on 18 Mar 2026 after an earnings release on 17 Mar 2026. The update left mixed signals: clinical progress supports long-term upside while negative EPS and high valuation multiples pressure near-term sentiment. We examine the latest 4592.T stock data, cash metrics, and how earnings details link to potential price targets.